Eterna Therapeutics
ERNA
#9576
Rank
NZ$45.58 M
Marketcap
$0.89
Share price
-2.29%
Change (1 day)
-44.97%
Change (1 year)

Eterna Therapeutics (ERNA) - P/B ratio

P/B ratio as of November 2024 : -3.13

According to Eterna Therapeutics's latest financial reports the company has a price-to-book ratio of 164.906.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Eterna Therapeutics - P/B ratio (from 2021 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-314.35218.94%
2022-12-311.36-83.98%
2021-12-318.51
2020-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
2.20-170.21%๐Ÿ‡บ๐Ÿ‡ธ USA
8.42-368.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-5.07 61.94%๐Ÿ‡บ๐Ÿ‡ธ USA
1.55-149.55%๐Ÿ‡ซ๐Ÿ‡ท France
5.30-269.01%๐Ÿ‡บ๐Ÿ‡ธ USA
3.03-196.60%๐Ÿ‡ฆ๐Ÿ‡บ Australia
3.04-196.97%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel